Catalyst Wire Dossier Catalyst Wire Dossier

TAXUS Element Paclitaxel-Eluting Coronary Stent System

paclitaxel-eluting coronary stent system · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAXUS Element Paclitaxel-Eluting Coronary Stent System, covering 2017-02-03 to 2017-02-03. Get the full timeline:

Most recent: Clinical Trial Update: TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)

See pricing